The chronic cytoprotection studies (Prkacin et al., 2001) and the adaptive cytoprotection research (Becejac et al., 2018) both demonstrate oral BPC-157 protects the GI tract from alcohol damage
Neither route is universally superior
But when I look at what the science says actually matters whole food sourcing, proven delivery technology, bioavailability, pre-digestion for absorption OHS is the only company Ive found that checks every box
Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
Harold July 11, 2026 To be honest I like the product, but I'm only 6 days deep in it so hard to make a good comparison but all good so far
Common range Community discussions reference 1-2 mg per day SubQ or 1-3% topical formulations
